Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1105 per EA under NDC 72888006301. Its NADAC has been published 209 times since Jun 29, 2022.
Strength
7.5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888006301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075521On Market Since
3/16/2021
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 209 times since Jun 29, 2022, and over the history we have for it it has declined 47.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1105 per EA |
|---|---|
| All-time high | $0.2119 (Jul 13, 2022) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1225 |
| 52-week low | $0.1105 |
| Median price | $0.1278 |
| Average price | $0.1356 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 209 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1105 per EA (NDC 72888006301), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 47.9%. It has been tracked across 209 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Jun 29, 2022, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.2119 (Jul 13, 2022), with a median of $0.1278 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 7.5 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 72888006301) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification